131

Index

A

  1. Ablin, Richard 61, 117
  2. advocates of prostate cancer screening 15–16
  3. age-standardised death rate from prostate cancer 34–36
  4. androgen deprivation therapy (ADT). See hormonal therapy
  5. astroturfing 113
  6. Australian Institute of Health and Welfare (AIHW) 45–46
  7. autopsy studies, results of 25–26

B

  1. benign prostatic hyperplasia (BPH) 22–23
  2. biopsy for prostate cancer 62
    1. side effects 62–63
  3. brachytherapy 73–74
  4. breast cancer 7
  5. breast cancer screening 109–10

C

  1. Cancer Council Australia 8, 12
  2. cancer incidence and death in Australia 29–31
  3. cancer journey 6
  4. cancer metaphors 5–6
  5. cancer screening. See screening for prostate cancer
  6. cancer’s grade 67
  7. cancer’s stage 65–66
  8. cervical cancer 7
  9. chemoprevention (finasteride) 54–55
  10. Coates, Alan 12–14
  11. Cochrane Collaboration 81–82
  12. Cochrane review 53
  13. colorectal cancer 7
  14. Costello, Tony 86

D

  1. da Vinci robotic surgery machine 84–85
  2. death in Australian men, causes of 28–29
  3. decision not to be tested 10
  4. diagnosis. See Prostate Specific Antigen (PSA) test
    1. downsides of 63–65
  5. diet 52
  6. dying with rather than from prostate cancer 49, 115 132

E

  1. ejaculatory frequency 56
  2. European Randomized Study of Screening for Prostate Cancer (ERSPC) 59, 97–100, 104, 117
  3. external beam radiation therapy (EBRT) 72–73

F

  1. false alarms, impact of 107
  2. family history, as a predictor of prostate cancer diagnosis 49–51

G

  1. Garvan Institute 46
  2. Giles, Andrew 46
  3. Gleason score 67–69
  4. grade of cancer 67
  5. green tea 53

H

  1. hormonal therapy 70, 73, 75
  2. hormone therapy (HT) 95

I

  1. inability to find problematic cancers 11
  2. indolent cancer 23, 93
  3. indolent prostate cancer 60

K

  1. Kooner, Raji 86

L

  1. laparoscopic prostatectomy 72
  2. Lloyd, Jim 15
  3. lycopene (tomatoes) 53

M

  1. male life expectancy 33
  2. mammography 110
  3. media coverage 10, 42, 44–48, 110, 114–15
  4. Movember campaign 10, 16

N

  1. nerve-sparing surgery 71
  2. NSW Central Cancer Registry 79
  3. NSW study (2009) 79–80, 83

O

  1. observational studies 95
  2. overdiagnosis 25, 105–06, 111
  3. overtreatment 105–06, 109–11, 115–16

P

  1. percentage change claims 17
  2. perineal prostatectomy 71
  3. physical activity 57
  4. prevention
    1. chemoprevention (finasteride) 54–55
    2. diet 52
    3. ejaculatory frequency 56
    4. green tea 53
    5. lycopene (tomatoes) 53
    6. physical activity 57
    7. selenium and vitamin E 53
  5. prostate 21
  6. prostate cancer as a cause of death 29–31, 115–16
  7. prostate cancer, definition 23
  8. Prostate Cancer Foundation of Australia (PCFA) 9, 42, 45–47, 50, 114
    1. Movember campaign 10, 16 133
  9. prostate cancer incidence 30–31, 34–35
    1. increases in 43
  10. prostate cancer mortality 31–32.
    1. See also age-standardised death rate from prostate cancer
    2. historic trends in 33–38
    3. rate 38, 112
  11. Prostate Cancer Prevention Trial 54–55
  12. prostatectomy
    1. laparoscopic 72
    2. negative side effects 12
    3. perineal 71
    4. radical 70
    5. retropubic 71
  13. Prostate Specific Antigen (PSA) discovery 61
    1. score 58–61
    2. test 11, 42–43, 58, 109
    3. testing, benefitting from 112–14
  14. prostatitis 21–22
  15. public awareness campaigns 13.
    1. See also astroturfing

R

  1. radical prostatectomy 70
  2. radiotherapy 72
    1. brachytherapy 73–74
    2. external beam radiation therapy (EBRT) 72–73
  3. randomised clinical/controlled trial 94, 96
  4. retropubic prostatectomy 71
  5. risks of prostate cancer diagnosis age-related 39–42
    1. test-related 42–43
  6. robotic-assisted surgery 86–88
  7. robotic prostatectomy 72
  8. Rochford, Andrew 47

S

  1. screening for prostate cancer
    1. benefits of 94–99
    2. decision aids 107
    3. definition of 89–91
    4. harmful effects of 105–07
    5. impact of screening for saving lives 97–102
    6. reasons for 91–94
    7. testing versus 108–09
  2. screening policies 7–9, 109
    1. criteria for assesing screening programs 92
  3. selenium and vitamin E 53
  4. sexual impotence 83
  5. Shine, John 46
  6. side effects of prostate cancer treatments
    1. bowel problems 83
    2. experienced specialist and 84
    3. risk of death 81
    4. sexual impotence 83
    5. studies of 77–80
    6. urinary incontinence 81–82
  7. stage of cancer 65–66
  8. Stricker, Phillip 87–88
  9. studies on the impact of information on the prostate cancer screening decisions 14, 18
  10. Swedish Göteborg study (2010) 103–04, 117
  11. 134

T

  1. thyroid cancer 24
  2. treatments for early stage prostate cancer 70–76.
    1. See also overdiagnosis
    2. hormonal therapy 75
    3. laparoscopic prostatectomy 72
    4. nerve-sparing surgery 71
    5. radical prostatectomy 70
    6. radiotherapy 72–74
    7. retropubic prostatectomy 71
    8. robotic prostatectomy 72, 86–88
    9. side effects 77–83, 116

U

  1. urinary incontinence 81–82
  2. Urological Society of Australia and New Zealand 43, 109
  3. US Preventive Services Task Force 8, 47–48
    1. 2008 review 105

V

  1. vitamin E and selenium 53

W

  1. watchful waiting 70
    1. study of 76–77

ABN: 15 211 513 464
CRICOS number: 00026A

© 2019 Sydney University Press